VEGF protein and mRNA expression in diabetic Gal-3 and WT mouse retina

Copyright information:Taken from "Inhibition of Advanced Glycation and Absence of Galectin-3 Prevent Blood-Retinal Barrier Dysfunction during Short-Term Diabetes"Experimental Diabetes Research 2007;2007():-.Published online 12 Apr 2007PMCID:PMC1880865. In WT mice (black bars) VEGF expression is significantly increased in diabetic (DB) retina—in terms of both protein (a) and mRNA expression (b) when compared to nondiabetic controls (NDB). PM-treatment significantly reduces VEGF expression in diabetic mice. In Gal-3 mice (white bars), retinal expression levels are not as dramatically increased by the presence of diabetes as evidenced in WT mice.